Guizhou Sanli - Public Comps and Valuation Multiples

Guizhou Sanli Overview

About Guizhou Sanli

Guizhou Sanli Pharmaceutical Co Ltd is engaged in Chinese pharmaceutical research, development, production and marketing. The company produces and sells soft capsules, hard capsules, sprays (including Chinese medicine extraction) and provides Chinese medicine science and technology consulting services. Its products include Pediatric medication; Respiratory system medication; Cardiovascular and cerebrovascular drugs; Digestive medicine; Trauma injury medication; Rehabilitation medicine; and Ophthalmic medicine.

Founded

1995

HQ

Employees

n/a

Website

gz-sanli.com

Sectors

Drug Development & Therapeutics
BioTech

Financials

LTM Revenue $259M

LTM EBITDA $57.6M

EV

$793M

Valuation Multiples

Multiples.vc

Valuation Multiples for 15K+ Public Comps

Benchmark forward-looking revenue and EBITDA valuation multiples across generative AI, climate tech, semiconductors, online marketplaces, vertical SaaS and 220 more verticals.

Browse Valuation Multiples

Guizhou Sanli Financials

As of September 2025, Guizhou Sanli reported last 12-month revenue of $259M and EBITDA of $57.6M.

In the same period, Guizhou Sanli generated $176M in LTM gross profit and $29.3M in net income.

See Guizhou Sanli valuation multiples based on analyst estimates

Guizhou Sanli P&L

In the most recent fiscal year, Guizhou Sanli reported revenue of $301M and EBITDA of $58.2M.

Guizhou Sanli expects next 12-month revenue of XXX and NTM EBITDA of XXX

See Guizhou Sanli valuation multiples based on analyst estimates

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue	$259M	XXX	$301M	XXX	XXX	XXX
Gross Profit	$176M	XXX	$209M	XXX	XXX	XXX
Gross Margin	68%	XXX	70%	XXX	XXX	XXX
EBITDA	$57.6M	XXX	$58.2M	XXX	XXX	XXX
EBITDA Margin	22%	XXX	19%	XXX	XXX	XXX
EBIT	$34.8M	XXX	$48.8M	XXX	XXX	XXX
EBIT Margin	13%	XXX	16%	XXX	XXX	XXX
Net Profit	$29.3M	XXX	$38.4M	XXX	XXX	XXX
Net Margin	11%	XXX	13%	XXX	XXX	XXX
Net Debt	XXX	XXX	$12.0M	XXX	XXX	XXX

Financial data powered by Morningstar, Inc.

.seo-only-financials-wrapper { position: static; left: auto; width: auto; height: auto; overflow: visible; }

Financial performance metrics for Guizhou Sanli including revenue, profitability, and margin analysis across different time periods. The company reported last twelve months revenue of $259M. EBITDA for the last twelve months was $57.6M. In the most recent fiscal year, Guizhou Sanli achieved $301M in revenue and $58.2M in EBITDA.
Financial Metric	Last Twelve Months (LTM)	Next Twelve Months (NTM)	Most Recent Fiscal Year	Current Fiscal Year (2025)	Next Fiscal Year (2026)	Two Years Forward (2027)
Total Revenue	$259M	Analyst estimates available to subscribers	$301M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit	$176M	Analyst estimates available to subscribers	$209M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Gross Profit Margin	67.7% gross margin	Analyst estimates available to subscribers	69.7% gross profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA (Earnings Before Interest, Taxes, Depreciation, Amortization)	$57.6M	Analyst estimates available to subscribers	$58.2M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBITDA Margin	22.2% EBITDA margin	Analyst estimates available to subscribers	19.4% EBITDA margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT (Earnings Before Interest and Taxes)	$34.8M	Analyst estimates available to subscribers	$48.8M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
EBIT Margin	13.4% EBIT margin	Analyst estimates available to subscribers	16.2% EBIT margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Income (Net Profit)	$29.3M	Analyst estimates available to subscribers	$38.4M	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Profit Margin	11.3% net profit margin	Analyst estimates available to subscribers	12.8% net profit margin	Analyst estimates available to subscribers	Analyst estimates available to subscribers	Analyst estimates available to subscribers
Net Debt Position	Detailed debt information available to subscribers	Detailed debt information available to subscribers	$12.0M	Detailed debt information available to subscribers	Detailed debt information available to subscribers	Detailed debt information available to subscribers

Financial Performance Summary for Guizhou Sanli

This financial data table provides comprehensive performance metrics for Guizhou Sanli, a company based in China. The metrics include revenue, profitability measures, and operational efficiency indicators across multiple time periods.

Recent Performance Highlights

Guizhou Sanli generated $259M in revenue over the last twelve months.
The company achieved $57.6M in EBITDA over the last twelve months.
Gross profit for the last twelve months was $176M.
Net income over the last twelve months reached $29.3M.

Fiscal Year Performance

In the most recent fiscal year, Guizhou Sanli reported $301M in total revenue.
Fiscal year EBITDA was $58.2M.
The company maintained a gross profit margin of 69.7% in the most recent fiscal year.
EBITDA margin for the fiscal year was 19.4%.
Net profit margin reached 12.8% in the most recent fiscal year.

This financial data is sourced from Morningstar, Inc. and represents the most recent available information for Guizhou Sanli. Forward-looking estimates and detailed financial projections are available through our premium subscription service.

Guizhou Sanli Stock Performance

Guizhou Sanli has current market cap of CNY 5.2B (or $726M), and EV of CNY 5.7B (or $793M).

Market Cap Evolution

Guizhou Sanli Stock Data

As of October 3, 2025, Guizhou Sanli's stock price is CNY 13 (or $2).

See Guizhou Sanli trading valuation data

EV	Market Cap	Price 1D	Price 1M	Price 3M	Price 12M	EPS
$793M	$726M	XXX	XXX	XXX	XXX	$0.07

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, next 12-month EV/Revenue, EBITDA multiples by industry and many more

Start Free Trial

Guizhou Sanli Valuation Multiples

Guizhou Sanli's trades at 2.6x EV/Revenue multiple, and 13.6x EV/EBITDA.

See valuation multiples for Guizhou Sanli and 15K+ public comps

Guizhou Sanli Financial Valuation Multiples

As of October 3, 2025, Guizhou Sanli has market cap of $726M and EV of $793M.

Equity research analysts estimate Guizhou Sanli's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX

Guizhou Sanli has a P/E ratio of 24.8x.

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Market cap (current)	$726M	XXX	$726M	XXX	XXX	XXX
EV (current)	$793M	XXX	$793M	XXX	XXX	XXX
EV/Revenue	3.1x	XXX	2.6x	XXX	XXX	XXX
EV/EBITDA	13.8x	XXX	13.6x	XXX	XXX	XXX
EV/EBIT	22.8x	XXX	16.2x	XXX	XXX	XXX
EV/Gross Profit	4.5x	XXX	n/a	XXX	XXX	XXX
P/E	24.8x	XXX	18.9x	XXX	XXX	XXX
EV/FCF	n/a	XXX	91.4x	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Get Guizhou Sanli Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2025, based on equity research analyst estimates.

Start Free Trial

Guizhou Sanli Margins & Growth Rates

Guizhou Sanli's last 12 month revenue growth is -2%

Guizhou Sanli's revenue per employee in the last FY averaged n/a, while opex per employee averaged n/a for the same period.

Guizhou Sanli's rule of 40 is 21% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).

Guizhou Sanli's rule of X is 18% (created by Bessemer, rule of X is another metric relevant for SaaS companies only, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).

See operational valuation multiples for Guizhou Sanli and other 15K+ public comps

Guizhou Sanli Operational Valuation Multiples

	LTM	NTM	Last FY	FY 2025	FY 2026	FY 2027
Revenue Growth	-2%	XXX	-7%	XXX	XXX	XXX
EBITDA Margin	22%	XXX	19%	XXX	XXX	XXX
EBITDA Growth	n/a	XXX	n/a	XXX	XXX	XXX
Rule of 40	21%	XXX	18%	XXX	XXX	XXX
Bessemer Rule of X	XXX	XXX	18%	XXX	XXX	XXX
Revenue per Employee	XXX	XXX	n/a	XXX	XXX	XXX
Opex per Employee	XXX	XXX	n/a	XXX	XXX	XXX
S&M Expenses to Revenue	XXX	XXX	36%	XXX	XXX	XXX
G&A Expenses to Revenue	XXX	XXX	n/a	XXX	XXX	XXX
R&D Expenses to Revenue	XXX	XXX	2%	XXX	XXX	XXX
Opex to Revenue	XXX	XXX	53%	XXX	XXX	XXX

Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 220+ Verticals

Benchmark public comps and private revenue and EBITDA valuation multiples across GRC software, cloud infrastructure, DevOps, online marketplaces and so much more!

Digital Therapeutics

Pharma Analytics

Private Equity

ERP Software

Developer Tools

Consumer SaaS

Streaming Platforms

Explore Valuation Multiples by Industry

Start Free Trial